Life Sciences Pioneer Todd Dickinson, Ph.D., Appointed as CEO; Spatial Biology Innovator Ye Fu, PhD., Appointed as CTO Boston – Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included Plaisance Capital Management and […]

AUSTIN, Texas and ASHLAND, Ore. — Parhelia Biosciences, the leader in sample preparation for tissue staining and spatial analysis, is pleased to announce the successful completion of its Series A financing round. This milestone is a testament to the company’s ongoing commitment to providing a single, modular solution for spatial biology sample preparation. The Series […]

Bionano announced today that it has priced a financing to raise an aggregate of $80.0 million in a registered offering and concurrent private placement of senior secured convertible notes due 2025 and warrants Preliminary Q3 revenue expected to be between $9.1 and $9.3 million, which would represent an estimated increase of 26% to 29% over Q3 2022 and would be […]

LUND, Sweden – Cellevate, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announced today the successful closure of its recent investment round, securing a total of 39 million SEK. The round was led by Industrifonden, in syndication with the European Innovation Council Fund (EIC Fund) and […]

Industrifonden and Navigare Ventures fund $7.3 million round STOCKHOLM — Pixelgen Technologies®, a leader in spatial proteomics for single cells, announced today that it has closed a Series A financing of approximately $7.3 million. The round was led by new investor Industrifonden, Sweden’s venture capital fund, and Navigare Ventures, an investor in Pixelgen’s Seed round. […]

Automata’s technology reduces drug development and testing timelines, costs and error rates – fundraise underlines strong investor & industry endorsement of its potential. Enables expansion of commercialisation strategy for efficiency-driving and capacity solving lab automation technology to the life sciences sector a leading automation company powering life sciences labs, has raised $40m to accelerate its […]

Saint-Sulpice, Switzerland Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal testing, is thrilled to announce the successful closure of its Series A funding round. The company has secured an oversubscribed 12.4M CHF investment from top-tier venture capital firms across Europe, co-led by Swisscanto and imec.xpand, together […]

Cambridge, UK – Eagle Genomics (“Eagle”) is pleased to announce it has raised additional financing of £3 million (USD $4 million) with continued participation from existing investors Environmental Technologies Fund, abrdn plc, and a consortium of investors headed by Granpool Innovative Investments, to further deploy its pioneering software platform that enables corporate customers to explore and monetize on microbiome-related […]

Financing led by M Ventures, with participation from GreatPoint Ventures, Riverine Ventures and existing investors Cota Capital, Dynamk Capital, Elm Street Ventures, Embark Ventures, EGB Capital and Khosla Ventures Novel microfluidics-based cell engineering platform for ex-vivo cell transfection enabling efficient, flexible, and consistent payload delivery, superior cell health and streamlined workflows for seamless scalability from […]

Maker of continuous real-time metabolic analysis systems experiences growing demand. Will build capacity for new product offerings, manufacturing, and global sales and marketing. ATLANTA–Lucid Scientific, a life science instruments company that manufactures Resipher, announced the completion of a $7 million Series A financing led by IAG Capital Partners. Additional participants include Lucid’s original investor base, […]